| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,528 |
24,610 |
$856K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,912 |
2,389 |
$94K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,006 |
2,500 |
$62K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,993 |
1,610 |
$58K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
571 |
545 |
$55K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
631 |
564 |
$33K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,304 |
991 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,379 |
1,148 |
$20K |
| 87428 |
|
296 |
278 |
$18K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
647 |
524 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
332 |
312 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
760 |
717 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
146 |
135 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
131 |
117 |
$5K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
391 |
334 |
$3K |
| 90674 |
|
150 |
130 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
407 |
372 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
94 |
91 |
$1K |
| 99215 |
Prolong outpt/office vis |
20 |
16 |
$970.85 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
30 |
28 |
$936.46 |
| 99201 |
|
26 |
22 |
$534.18 |
| 90686 |
|
17 |
16 |
$232.41 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
154 |
139 |
$94.36 |
| A4206 |
Syringe with needle, sterile, 1 cc or less, each |
1,253 |
1,032 |
$75.43 |
| 81002 |
|
44 |
37 |
$35.55 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
12 |
$25.34 |
| 87807 |
|
12 |
12 |
$12.70 |
| G0008 |
Administration of influenza virus vaccine |
18 |
13 |
$8.44 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
148 |
87 |
$0.07 |